* Inari Medical Inc NARI.OQ reported a quarterly adjusted
loss
of 19 cents per share for the quarter ended in September. The
mean expectation of eight analysts for the quarter was for a
loss of 25 cents per share.
* Revenue rose 31.9% to $96.20 million from a year ago;
analysts
expected $90.40 million.
* Inari Medical Inc's reported EPS for the quarter was a
loss
of 19 cents.
* The mean earnings estimate of analysts had fallen by
about 5.7%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Inari Medical Inc shares had risen by 3.6% this
quarter and
lost 17.5% so far this year.
* The company reported a quarterly loss of $10.15 million.
* Wall Street's median 12-month price target for Inari
Medical Inc
is $94.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
2 at 09:40 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.25 -0.19 Beat
Jun. 30 2022 -0.23 -0.19 Beat
Mar. 31 2022 -0.09 -0.06 Beat
Dec. 31 2021 0.03 0.02 Missed